As of 2025-07-19, the Relative Valuation of Paratek Pharmaceuticals Inc (PRTK) is (20.82) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.23 USD, the upside of Paratek Pharmaceuticals Inc based on Relative Valuation is -1033.7%.
The range of the Relative Valuation is (20.66) - (19.90) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 18.2x | 18.0x |
| Forward P/E multiples | 18.9x - 22.4x | 20.1x |
| Fair Price | (20.66) - (19.90) | (20.82) |
| Upside | -1026.6% - -992.2% | -1033.7% |
| Date | P/E |